Exploring ethical responsibilities of researchers in community-based clinical trials
Official title: Researcher Responsibilities’ to Non-Participants in Community-based Pragmatic Clinical Trials
Funded at New York University School of Medicine · NIH-11063645 · Data updated 2026-11-12
This study looks at how researchers can ethically support communities while running heart disease trials, especially in areas that need more help, to make sure everyone involved gets the most benefit and protection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $169,478 |
| NIH project number | 3R01HL168597-02S1 |
| Project ID | NIH-11063645 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals from under-resourced communities who are affected by cardiovascular diseases and may participate in or be impacted by community-based clinical trials.
✕Less likely to help
Patients who are not part of under-resourced communities or those who do not have cardiovascular diseases may not receive direct benefits from this research.
What this research studies
This research investigates the ethical responsibilities of researchers conducting community-based pragmatic clinical trials (PCTs) focused on cardiovascular disease. It aims to understand how these trials can better serve under-resourced populations by addressing ethical concerns related to participant and non-participant interactions. The study will analyze the implications of conducting trials in real-world settings, where researchers may have the opportunity to provide support and resources to the communities involved. By examining these ethical dimensions, the research seeks to enhance the protection and benefit of communities participating in clinical trials.
Why it matters
Potential benefit: If successful, this research could lead to improved ethical standards and practices in clinical trials, ultimately benefiting communities by ensuring they receive support and resources beyond the research itself.
How similar studies have gone: While the ethical considerations of community-based PCTs are increasingly recognized, this research addresses a relatively novel area that has not been extensively explored in prior studies.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Newman, Jonathan D — New York University School of Medicine
- Study coordinator: Newman, Jonathan D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.